A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
EP-1122: Efficacy and safety of stereotactic reirradiation for recurrent brain metastases
2016
Radiotherapy and Oncology
Results: A total of 26 lesions were included in the analysis. Median follow-up was 14 months (3-41 months). Thirteen were metastatic lesions with histology as breast cancer, medulloblastoma, adenoid cystic among others. Response rates were: 31% complete response and partial response / stable at 69%. 13 benign lesions highlighting arteriovenous malformations, neurofibroma and melanocytoma. Response rates for this group: complete response in 8%, partial response / stable at 92%. During the
doi:10.1016/s0167-8140(16)32372-6
fatcat:kplvkjzp7baalka5awcv42fvye